ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

CDC: Overdose deaths from counterfeit drugs on the rise CDC: Overdose deaths from counterfeit drugs on the rise

CDC: Overdose deaths from counterfeit drugs on the rise

0 6219

A new report from CDC finds that in recent years, the number of people who overdosed and died from counterfeit prescription drugs has more than doubled. From mid-2019 to the end of 2021, overdose deaths involving counterfeit drugs increased from 2% to 4.7%.

Postnatal SSRI treatment could benefit both mother and child Postnatal SSRI treatment could benefit both mother and child

Postnatal SSRI treatment could benefit both mother and child

0 5959
Findings from a recent study published in JAMA Network Open suggest that postnatal SSRI treatment may bring benefits in the long term to not only mothers, but also their offspring.
Is PPI use connected to dementia risk? Is PPI use connected to dementia risk?

Is PPI use connected to dementia risk?

The prolonged use of PPI drugs, which are designed to control acid reflux and other gastrointestinal disorders, may raise the risk of dementia,...
0 6993
CDC: MMR vaccinations fall for children CDC: MMR vaccinations fall for children

CDC: MMR vaccinations fall for children

According to new CDC data, the rate of vaccinations against measles, mumps, and rubella (MMR) for kindergarteners has fallen below the optimum...
0 6405
Hospital pharmacists say drug shortages are affecting care Hospital pharmacists say drug shortages are affecting care

Hospital pharmacists say drug shortages are affecting care

New survey findings from the American Society of Health-System Pharmacists (ASHP) shows that roughly 99% of health-system pharmacists said they...
0 8616
Few adults receive medication for opioid use disorder Few adults receive medication for opioid use disorder

Few adults receive medication for opioid use disorder

A new study in JAMA Network Open found that as drug overdose deaths have reached unprecedented levels in the United States, evidence-based...
0 6365

CDC recommends new drug to protect infants from RSV

In July, FDA approved nirsevimab-alip (Beyfortus—Sanofi/AstraZeneca). A few weeks later, on August 3, 2023, CDC’s ACIP voted unanimously to recommend the broad use of the new drug to infants and high-risk children for protection against respiratory syncytial virus (RSV).
First34568101112Last
ADVERTISEMENT